http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 12 Feb 2026 16:21:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVAI+BIO%2C+INC.++++++++++++For%3A+Dec+31/25992262.html si-local-file:///var/storage/secattach/20260212/25992262.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVAI+BIO%2C+INC.++++++++++++For%3A+Dec+31/25992262.html Thu, 12 Feb 2026 16:21:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVAI+BIO%2C+INC.++++++++++++For%3A+Dec+31/25992262.html si-local-file:///var/storage/secattach/20260212/25992262.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVAI+BIO%2C+INC.++++++++++++For%3A+Dec+31/25992262.html Thu, 12 Feb 2026 16:21:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVAI+BIO%2C+INC.++++++++++++For%3A+Dec+31/25992262.html si-local-file:///var/storage/secattach/20260212/25992262.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVAI+BIO%2C+INC.++++++++++++For%3A+Dec+31/25992262.html Thu, 12 Feb 2026 16:21:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Feb+03/25965543.html si-local-file:///var/storage/secattach/20260209/25965543.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Feb+03/25965543.html Mon, 09 Feb 2026 08:52:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Feb+03/25965543.html si-local-file:///var/storage/secattach/20260209/25965543.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Feb+03/25965543.html Mon, 09 Feb 2026 08:52:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Feb+03/25965543.html si-local-file:///var/storage/secattach/20260209/25965543.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Feb+03/25965543.html Mon, 09 Feb 2026 08:52:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Sep+30/25610795.html si-local-file:///var/storage/secattach/20251114/25610795.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Sep+30/25610795.html Fri, 14 Nov 2025 06:11:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Sep+30/25610795.html si-local-file:///var/storage/secattach/20251114/25610795.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Sep+30/25610795.html Fri, 14 Nov 2025 06:11:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Sep+30/25610795.html si-local-file:///var/storage/secattach/20251114/25610795.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Sep+30/25610795.html Fri, 14 Nov 2025 06:11:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Nov+01/25548949.html si-local-file:///var/storage/secattach/20251104/25548949.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Nov+01/25548949.html Tue, 04 Nov 2025 07:23:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Nov+01/25548949.html si-local-file:///var/storage/secattach/20251104/25548949.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Nov+01/25548949.html Tue, 04 Nov 2025 07:23:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Nov+01/25548949.html si-local-file:///var/storage/secattach/20251104/25548949.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVANT+TECHNOLOGIES+INC.+++For%3A+Nov+01/25548949.html Tue, 04 Nov 2025 07:23:00 -0400 AVAI O.41514066 TREN http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/Press+Releases/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html <div class="xn-content"> <p> <span class="legendSpanClass"><location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 21, 2025</chron></span> /PRNewswire/ -- <span value="ACORN:0355019569" idsrc="xmltag.org" >Avant Technologies Inc.</span> (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, <span>Klothonova LLC</span>, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for http://www.streetinsider.com/PRNewswire/Avant+Technologies+and+Austrianova+Launch+Klothonova%2C+Begin+Developing+Age+Related+Cellular+Therapies+Using+%27Longevity+Protein%27+Klotho/25479383.html Tue, 21 Oct 2025 08:00:00 -0400 A.03550195 A.50211433 AVAI O.00082247 O.17509382 O.35272431 O.41514066 TREN